FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         	UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  	OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5	
                      	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	                      	

1. Name and Address of Reporting Person *

LEVITAN DAN	2. Issuer Name and Ticker or Trading Symbol

TRUPANION, INC. [ TRUP ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)	
(Last)         (First)         (Middle)

411 FIRST AVENUE SOUTH, SUITE 600	3. Date of Earliest Transaction (MM/DD/YYYY)

11/13/2019		
(Street)

SEATTLE, WA 98104
(City)       (State)       (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)

11/15/2019 	6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person	

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned	
1.Title of Security
(Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code
(Instr. 8)	4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)	
			Code	V	Amount	(A) or (D)	Price				
Common Stock 	11/13/2019 	 	J(1)	  	211947 	D	$0 	638881 	I 	See footnote (2)	
Common Stock 	11/13/2019 	 	J(3)	  	2075 	A	$0 	7854 	I 	See footnote (3)	
Common Stock 	11/13/2019 	 	J(4)	  	29061 	D	$0 	87599 	I 	See footnote (5)	
Common Stock 	11/13/2019 	 	J(6)	  	8992 	D	$0 	27106 	I 	See footnote (7)	
Common Stock 	11/13/2019 	 	J(8)	  	90 	A	$0 	7944 	I 	See footnote (8)	
Common Stock 	11/13/2019 	 	J(9)	  	1252 	D	$0 	6692 	I 	See footnote (10)	
Common Stock 	11/13/2019 	 	J(11)	  	109 	A	$0 	4507 	I 	See footnote (12)	
Common Stock 	11/13/2019 	 	J(13)	  	4577 	A	$0 	79628 	D 	 	
Common Stock 	 	 	 	  	 	 	 	23000 	I 	By Trust - Levitan Family Foundation (14)	

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)	
1. Title of Derivate Security
(Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code
(Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)	6. Date Exercisable and Expiration Date	7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)	8. Price of Derivative Security
(Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)	
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares					

Explanation of Responses:	
(1) 	Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 211,947 shares of common stock of the issuer to its partners on November 13, 2019.	
(2) 	Shares are owned directly by Maveron Equity. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, and may be deemed to share voting and investment power over the securities held by Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(3) 	Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(4) 	MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 29,061 shares of common stock of the issuer to its partners on November 13, 2019.	
(5) 	Shares are owned directly by Maveron Associates. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Associates, and may be deemed to share voting and investment power over the securities held by Maveron Associates. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(6) 	Maveron III Entrepreneurs Fund, L.P. ("Maveron Entrepreneurs") made pro rata distributions for no consideration of 8,992 shares of common stock of the issuer to its partners on November 13, 2019.	
(7) 	Shares are owned directly by Maveron Entrepreneurs. The reporting person, together with Clayton Lewis, Peter McCormick and Jason Stoffer, are members of Maveron GP, which is the general partner of Maveron Entrepreneurs, and may be deemed to share voting and investment power over the securities held by Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(8) 	Shares acquired and owned directly by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(9) 	Maveron GP distributed for no consideration 1,252 shares of common stock of the issuer to its members on November 13, 2019.	
(10) 	Shares owned directly by Maveron GP.	
(11) 	Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron Associates.	
(12) 	Shares are owned directly by Maveron LLC. The reporting person is a member of Maveron LLC, and may be deemed to share voting and investment power over the securities held by Maveron LLC. The reporting person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.	
(13) 	Shares acquired by the reporting person in connection with the distribution of such shares to the partners of Maveron Associates.	
(14) 	Shares are held by a trust the holdings of which are attributable to the reporting person.	

Remarks:
Each reporting person disclaims the existence of a "group" and disclaims beneficial ownership of any securities except to the extent of such reporting persons' pecuniary interest in such securities.	

Reporting Owners	
Reporting Owner Name / Address	Relationships	
	Director	10% Owner	Officer	Other	
LEVITAN DAN
411 FIRST AVENUE SOUTH, SUITE 600
SEATTLE, WA 98104	X				

Signatures		
/s/ Dan Levitan		6/1/2020	
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.	
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).	
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).	
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.	
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.